Open-Label, Randomized, Split-Face Study to Evaluate the Efficacy, Safety and Subject Satisfaction of Pain Management During and After Restylane Dermal Filler Injections for the Correction of Nasolabial Folds
Phase of Trial: Phase IV
Latest Information Update: 25 Mar 2014
At a glance
- Drugs Benzocaine; Lidocaine/tetracaine
- Indications Injection site pain
- Focus Therapeutic Use
- Sponsors Galderma
- 03 Feb 2010 Patient numbers amended from 57 to 51 as reported by ClinicalTrials.gov.
- 30 Sep 2008 Planned end date changed from 1 Oct 2008 to 1 Sep 2008 as reported by ClinicalTrials.gov.
- 30 Sep 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.